Company news

Avita Medical, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

AVITA Medical Announces Management Changes and Fourth Quarter 2022 Earnings Conference Call

January 18, 2023

AVITA Medical Submits FDA PMA Application to Expand Indication to Vitiligo

December 18, 2022

AVITA Medical Submits FDA PMA Supplement to Further Expand Indication to Soft Tissue Repair

December 11, 2022

AVITA Medical Announces Results of 2022 Annual Meeting of Stockholders

December 11, 2022

AVITA Medical Reports Third Quarter 2022 Financial Results

November 9, 2022

AVITA Medical Announces Achievement of Co-Primary Endpoints in Updated Analysis of Pivotal Trial of RECELL® System for Soft Tissue Repair

November 8, 2022

AVITA Medical Announces FDA Breakthrough Device Designations for the RECELL® System

November 2, 2022

AVITA Medical to Announce Third Quarter 2022 Financial Results

October 19, 2022

AVITA Medical Appoints Industry Leader James Corbett as Chief Executive Officer

September 27, 2022

AVITA Medical Achieves Positive Topline Pivotal Trial Results for Treatment of Stable Vitiligo Using the RECELL® System

September 11, 2022

RECELL System Insurance Coverage Begins in Japan for Treatment of Acute Burns

August 31, 2022

AVITA Medical Reports Second Quarter 2022 Financial Results

August 10, 2022

AVITA Medical Announces Topline Results from Pivotal Trial in Patients with Soft-Tissue Injuries using the RECELL® System

August 10, 2022

AVITA Medical to Announce Second Quarter 2022 Financial Results

July 24, 2022

AVITA Medical Reports First Quarter 2022 Financial Results

May 11, 2022

AVITA Medical to Announce First Quarter 2022 Financial Results

April 27, 2022

Avita Medical, Inc. Announces Resignation of Louis Drapeau from Board of Directors

April 20, 2022

AVITA Medical Announces Modification of BARDA Contract to Advance Development of RECELL® System in Soft Tissue Reconstruction

March 20, 2022

Avita Medical, Inc. Signs Agreement with Premier, Inc. to Supply the RECELL® System to Hospitals and Health Systems Across the U.S.

March 1, 2022

AVITA Medical Reports Quarter Ending December 31, 2021, and Transition Period July 1, 2021, to December 31, 2021, Financial Results

February 27, 2022

The RECELL® System Receives PMDA Approval in Japan and AVITA Medical will Commercialize in Partnership with COSMOTEC, an M3 Group Company

February 22, 2022

AVITA Medical Announces FDA Approval of New RECELL® System with Improved Ease of Use

February 16, 2022

AVITA Medical Announces Preliminary Unaudited Results for the Quarter ended December 31, 2021

January 9, 2022

AVITA Medical Completes Enrollment in Pivotal Trial Evaluating the RECELL® System for Soft-Tissue Reconstruction

January 5, 2022

AVITA Medical Completes Enrollment in Pivotal Trial Evaluating the RECELL® System for Repigmentation of Stable Vitiligo

December 14, 2021

AVITA Medical, Inc. Announces Adjournment of 2021 Annual Stockholder Meeting

December 13, 2021

AVITA Medical Reports First Fiscal Quarter 2022 Financial Results

November 7, 2021

AVITA Medical Announces Expanded Medicare Reimbursement to Outpatient Hospital and Ambulatory Surgical Centers

November 2, 2021

AVITA Medical to Announce Fiscal First Quarter 2022 Financial Results

October 24, 2021

AVITA Medical Reports Fourth Quarter and Fiscal Year 2021 Financial Results

August 25, 2021

FDA Approves IDE Amendment to a Single-Arm Design for AVITA Medical’s Pivotal Study of the RECELL® System for Vitiligo Treatment

August 15, 2021

AVITA Medical to Announce Fiscal Fourth Quarter 2021 Financial Results

August 11, 2021

AVITA Medical Announces Inclusion in the Russell 3000 Index

June 28, 2021

AVITA Medical Announces Preliminary Fourth Quarter 2021 Financial Results

June 14, 2021

U.S. Food and Drug Administration Approves Expanded Use of the RECELL® System for the Treatment of Extensive Burns and Pediatric Patients

June 9, 2021

AVITA Medical, Inc. Appoints Two New Non-Executive Members to the Board of Directors

May 31, 2021

AVITA Medical Reports Third Quarter 2021 Financial Results

May 12, 2021

AVITA Medical to Announce Fiscal Third Quarter 2021 Financial Results

April 28, 2021

AVITA Medical, Inc. Names Michael Holder as Chief Financial Officer

March 21, 2021

Avita Medical, Inc. Announces Closing of Offering of 3,214,250 Shares of Common Stock

February 28, 2021

AVITA Medical, Inc. Announces Pricing of Its Public Offering of Common Stock

February 24, 2021

AVITA Medical, Inc. Announces Proposed Public Offering of Common Stock

February 23, 2021

AVITA Medical Reports Full Second Quarter 2021 Financial Results

February 10, 2021

AVITA Medical to Announce Fiscal Second Quarter 2021 Financial Results

January 27, 2021

AVITA Medical Announces Preliminary Fiscal Second Quarter 2021 Results

January 11, 2021

AVITA Therapeutics Appoints Kathy McGee as Chief Operating Officer

November 30, 2020

AVITA Therapeutics Reports First Quarter 2021 Financial Results

November 9, 2020

AVITA Therapeutics, Inc. Announces Executive Change

November 4, 2020

AVITA Therapeutics Announces Date Change for First Quarter 2021 Earnings Release and Conference Call

November 2, 2020

AVITA Therapeutics, Inc. Announces Adjournment of 2020 Annual Stockholder Meeting

October 28, 2020

← Newer news releases · Older news releases →

Calls

The 5 newest of 22 calls. Every call is listed under its year.

Decks

The 5 newest of 55 decks. Every deck is listed under its year.